FDA Approved: GUANFACINE EXTENDED-RELEASE — Supplemental Application (Apotex Corp.)

View source ↗

Summary

FDA approved a supplemental ANDA for guanfacine extended-release (generic) to Apotex Corp., granting regulatory approval for the generic product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Attention Deficit Hyperactivity Disorder

Drugs mentioned

• Guanfacine Extended Release (guanfacine)

Snippet

SUPPL AP for GUANFACINE EXTENDED-RELEASE (GUANFACINE)